MLST8
Target of rapamycin complex subunit LST8
As of the edition of 20 October 2026, MLST8 (target of rapamycin complex subunit LST8, UniProt Q9BVC4) has 1 drug tested at it and 1 company on the list, 0 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q9BVC4
- How well studied
- Biology documented; no tool compounds or approved drug yet
- Where it sits in the cell
- In more than one place
- Solved structures
- 46
- Disease areas
- Cancer; Skin and connective tissue; Nervous system; Digestive system; Hormones; Lungs and airways; Urinary and reproductive
- Registered trials of its drugs
- 16
Drugs at this target
| Status | Count |
|---|---|
| Stopped | 1 |
| Total | 1 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Indoximod | Stopped | Phase 2 | none listed |
1 of 1 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Undetermined | 1 |
| Total on the list | 1 |